Mizuho Securities USA LLC Takes $5.40 Million Position in Drugs Made In America Acquisition Corp. (NASDAQ:DMAA)

Key Points

• Mizuho Securities USA LLC purchased 542,962 shares of Drugs Made In America Acquisition Corp. (NASDAQ:DMAA) valued at approximately $5.4 million, representing about 1.86% of the company as per the latest SEC disclosure.
• As of the latest trading session, shares of DMAA opened at $10.26, with a 1-year price range between $9.95 and $10.28.
• Drugs Made In America Acquisition Corp. is a blank check company based in the Cayman Islands, focusing on mergers and acquisitions.

Mizuho Securities USA LLC bought a new stake in shares of Drugs Made In America Acquisition Corp. (NASDAQ:DMAA - Free Report) in the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor bought 542,962 shares of the company's stock, valued at approximately $5,402,000. Mizuho Securities USA LLC owned about 1.86% of Drugs Made In America Acquisition at the end of the most recent reporting period.

Drugs Made In America Acquisition Stock Performance

Shares of DMAA stock traded up $0.03 during trading hours on Thursday, reaching $10.28. 878 shares of the stock traded hands, compared to its average volume of 101,970. Drugs Made In America Acquisition Corp. has a 1-year low of $9.95 and a 1-year high of $10.28.

About Drugs Made In America Acquisition

Drugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.